Myeloid antigens in childhood lymphoblastic leukemia:clinical data point to regulation of CD66c distinct from other myeloid antigens
<p>Abstract</p> <p>Background</p> <p>Aberrant expression of myeloid antigens (MyAgs) on acute lymphoblastic leukemia (ALL) cells is a well-documented phenomenon, although its regulating mechanisms are unclear. MyAgs in ALL are interpreted e.g. as hallmarks of early diff...
Main Authors: | Madzo Jozef, Mejstrikova Ester, Vaskova Martina, Kalina Tomas, Trka Jan, Stary Jan, Hrusak Ondrej |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-04-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/5/38 |
Similar Items
-
Prognostic value of myeloid antigens expression in childhood acute lymphoblastic leukemia
by: Aula Mahmood Ibrahim, et al.
Published: (2017-01-01) -
Recent advances in the management of pediatric acute lymphoblastic leukemia [version 1; referees: 2 approved]
by: Jan Starý, et al.
Published: (2016-11-01) -
Impact of Aberrant Myeloid Antigen Expression on Outcomes of Patients with T-cell Acute Lymphoblastic Leukemia
by: Mohamed Al-Zaabi, et al.
Published: (2017-05-01) -
The clinical importance of myeloid antigen coexpression and TEL-AML1 mutation in patients with childhood acute lymphoblastic leukemia
by: Ayşen Türedi Yıldırım, et al.
Published: (2013-03-01) -
Frequency of cancer testis antigens in chronic myeloid leukemia
by: I. Mendoza-Salas, et al.
Published: (2016-04-01)